TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival
Journal of Clinical Oncology · 10.08.2026 · 44 (23) · 2254-2255
DOI: 10.1200/jco-26-00267 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.08.2026. Verfasst von Noah S Meimoun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Noah S. Meimoun, BA, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Noah S. Meimoun, BA, Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; Alexander D. Sherry, MD, Department of Radiation Oncology, The Mayo…
ORCID-Profile: Noah S Meimoun, Alexander D Sherry, Ethan B Ludmir, Timothy A Lin
Zitieren
APA
Meimoun, N. S., Sherry, A. D., Ludmir, E. B., & Lin, T. A. (2026). TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival. Journal of Clinical Oncology, 44(23), 2254-2255. https://doi.org/10.1200/jco-26-00267
Vancouver
Meimoun NS, Sherry AD, Ludmir EB, Lin TA. TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival. Journal of Clinical Oncology. 2026;44(23):2254-2255. doi:10.1200/jco-26-00267
BibTeX
@article{Meimoun2026,
author = {Meimoun, Noah S and Sherry, Alexander D and Ludmir, Ethan B and Lin, Timothy A},
title = {TRIPLETE But Incomplete? Accounting for Postprogression Therapy When Interpreting Overall Survival},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {23},
pages = {2254--2255},
doi = {10.1200/jco-26-00267}
}
EUVIMED